Not later than October 1, 2024, the board shall develop and submit to the governor, the legislature, and the Legislative Budget Board a business plan on:
(1) implementing the initiative, including the initiative’s organizational structure and related programs;
(2) establishing procedures and policies for the administration of the initiative, including documenting the process and resources required for the provision to individuals described by § 2177.002 of the following services:
(A) establishing or contracting for statewide pharmacy benefit manager services;
(B) establishing policies and conditions to operate or contract for the operation of a distribution network, central service center, and associated network of satellite distribution facilities to distribute prescription drugs and related medical supplies; and
(C) providing advanced pharmaceutical preparation and related services, including:
(i) manufacturing generic drugs and generic biological products;
(ii) providing gene therapies and precision medicine; and
(iii) providing advanced laboratories for quality control, preparation, and compounding of drugs in support of innovative therapeutics and drug research;
(3) establishing procedures to document compliance by board members and personnel with applicable laws governing conflicts of interest;
(4) establishing the conditions for state agencies that facilitate health plans to participate in the initiative;
(5) identifying potential cost savings from implementation of the initiative;
(6) identifying the funding and resources needed to implement this chapter; and
(7) providing other board recommendations, with supporting documentation, on continuation of the initiative.